Neuroprotective actions of thyroid hormones and low-T3 syndrome as a biomarker in acute cerebrovascular disorders

References

• Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics – 2013 update: a report from the American Heart Association. Circulation 2013;127(1):e6-e245
   PubMed Web of Science ®Google Scholar
• Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet 2008;371(9624):1612-23
   PubMed Web of Science ®Google Scholar
• Kinlay S. Changes in stroke epidemiology, prevention, and treatment. Circulation 2011;124(19):e494-6
   Google Scholar
• Redon J, Olsen MH, Cooper RS, et al. Stroke mortality and trends from 1990 to 2006 in 39 countries from Europe and Central Asia: implications for control of high blood pressure. Eur Heart J 2011;32(11):1424-31
   PubMed Web of Science ®Google Scholar
• Mukherjee D, Patil CG. Epidemiology and the global burden of stroke. World Neurosurg 2011;76(6 Suppl):S85-90
   PubMed Web of Science ®Google Scholar
• Norrving B, Kissela B. The global burden of stroke and need for a continuum of care. Neurology 2013;80(3 Suppl 2):S5-12
   PubMed Web of Science ®Google Scholar
• Jauch EC, Saver JL, Adams HPJr, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013;44(3):870-947
   PubMed Web of Science ®Google Scholar
• Connolly ESJr, Rabinstein AA, Carhuapoma JR, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association. Stroke 2012;43(6):1711-37
   PubMed Web of Science ®Google Scholar
• Whiteley W, Chong WL, Sengupta A, Sandercock P. Blood markers for the prognosis of ischemic stroke: a systematic review. Stroke 2009;40(5):e380-9
   PubMed Web of Science ®Google Scholar
• Jickling GC, Sharp FR. Blood biomarkers of ischemic stroke. Neurotherapeutics 2011;8(3):349-60
   PubMed Web of Science ®Google Scholar
• Pedraza S, Puig J, Blasco G, et al. Magnetic resonance imaging biomarkers of ischemic stroke: criteria for the validation of primary imaging biomarkers. Drug News Perspect 2009;22(8):481-6
   Google Scholar
• Bunevicius A, Yuan H, Lin W. The potential roles of (18) F-FDG-PET in management of acute stroke patients. Biomed Res Int 2013;2013:634598
   Web of Science ®Google Scholar
• Rothstein L, Jickling GC. Ischemic stroke biomarkers in blood. Biomarkers Med 2013;7(1):37-47
   PubMed Web of Science ®Google Scholar
• Katan M, Elkind MS. Inflammatory and neuroendocrine biomarkers of prognosis after ischemic stroke. Expert Rev Neurother 2011;11(2):225-39
   PubMed Web of Science ®Google Scholar
• Tu WJ, Dong X, Zhao SJ, et al. Prognostic value of plasma neuroendocrine biomarkers in patients with acute ischaemic stroke. J Neuroendocrinol 2013;25(9):771-8
   PubMed Web of Science ®Google Scholar
• Winzeler BF, Christ-Crain M. Hormones as biomarkers for diagnosis and prognosis. Praxis 2012;101(4):251-7
   Google Scholar
• Maas MB, Furie KL. Molecular biomarkers in stroke diagnosis and prognosis. Biomarkers Med 2009;3(4):363-83
   Google Scholar
• Alevizaki M, Synetou M, Xynos K, et al. Low triiodothyronine: a strong predictor of outcome in acute stroke patients. Eur J Clin Invest 2007;37(8):651-7
   PubMed Web of Science ®Google Scholar
• Zhang Y, Meyer MA. Clinical analysis on alteration of thyroid hormones in the serum of patients with acute ischemic stroke. Stroke Res Treat 2010;2010 [Article ID 290678, 5 pages]
   Google Scholar
• Neidert S, Katan M, Schuetz P, et al. Anterior pituitary axis hormones and outcome in acute ischaemic stroke. J Intern Med 2011;269(4):420-32
   PubMedGoogle Scholar
• Ambrosius W, Kazmierski R, Gupta V, et al. Low free triiodothyronine levels are related to poor prognosis in acute ischemic stroke. Exp Clin Endocrinol Diabetes 2011;119(3):139-43
   Google Scholar
• Bunevicius A, Kazlauskas H, Raskauskiene N, et al. Ischemic stroke functional outcomes are independently associated with C-reactive protein concentrations and cognitive outcomes with triiodothyronine concentrations: a pilot study. Endocrine 2013;45(2):213-20
   Google Scholar
• Forti P, Maioli F, Coveri M, et al. Thyroid function tests and early outcomes of acute ischemic stroke in older euthyroid patients. Exp Gerontol 2014;61C:8-14
   Google Scholar
• Zetterling M, Engstrom BE, Arnardottir S, Ronne-Engstrom E. Somatotropic and thyroid hormones in the acute phase of subarachnoid haemorrhage. Acta Neurochir (Wien) 2013;155(11):2053-62
   PubMed Web of Science ®Google Scholar
• Bianco AC, Salvatore D, Gereben B, et al. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 2002;23(1):38-89
   PubMed Web of Science ®Google Scholar
• Williams GR. Neurodevelopmental and neurophysiological actions of thyroid hormone. J Neuroendocrinol 2008;20(6):784-94
   PubMed Web of Science ®Google Scholar
• Brent GA. The molecular basis of thyroid hormone action. N Engl J Med 1994;331(13):847-53
   Google Scholar
• Cheng SY, Leonard JL, Davis PJ. Molecular aspects of thyroid hormone actions. Endocr Rev 2010;31(2):139-70
   PubMed Web of Science ®Google Scholar
• Davis PJ, Davis FB, Mousa SA, et al. Membrane receptor for thyroid hormone: physiologic and pharmacologic implications. Annu Rev Pharmacol Toxicol 2011;51:99-115
   PubMed Web of Science ®Google Scholar
• Faustino LC, Ortiga-Carvalho TM. Thyroid hormone role on cerebellar development and maintenance: a perspective based on transgenic mouse models. Front Endocrinol (Lausanne) 2014;5:75
   Google Scholar
• Lourbopoulos A, Mourouzis I, Karapanayiotides T, et al. Changes in thyroid hormone receptors after permanent cerebral ischemia in male rats. J Mol Neurosci 2014;54(1):78-91
   Google Scholar
• Vose LR, Vinukonda G, Jo S, et al. Treatment with thyroxine restores myelination and clinical recovery after intraventricular hemorrhage. J Neurosci 2013;33(44):17232-46
   Google Scholar
• Warner MH, Beckett GJ. Mechanisms behind the non-thyroidal illness syndrome: an update. J Endocrinol 2010;205(1):1-13
   PubMed Web of Science ®Google Scholar
• De Groot LJ. Non-thyroidal illness syndrome is a manifestation of hypothalamic-pituitary dysfunction, and in view of current evidence, should be treated with appropriate replacement therapies. Crit Care Clin 2006;22(1):57-86, vi
   PubMed Web of Science ®Google Scholar
• Iervasi G, Pingitore A, Landi P, et al. Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation 2003;107(5):708-13
   PubMed Web of Science ®Google Scholar
• Scoscia E, Baglioni S, Eslami A, et al. Low triiodothyronine (T3) state: a predictor of outcome in respiratory failure? Results of a clinical pilot study. Eur J Endocrinol 2004;151(5):557-60
   PubMed Web of Science ®Google Scholar
• Plikat K, Langgartner J, Buettner R, et al. Frequency and outcome of patients with nonthyroidal illness syndrome in a medical intensive care unit. Metabolism 2007;56(2):239-44
   PubMed Web of Science ®Google Scholar
• Bunevicius A, Deltuva V, Tamasauskas S, et al. Low triiodothyronine syndrome as a predictor of poor outcomes in patients undergoing brain tumor surgery: a pilot study: clinical article. J Neurosurg 2013;118(6):1279-87
   PubMed Web of Science ®Google Scholar
• Genovese T, Impellizzeri D, Ahmad A, et al. Post-ischaemic thyroid hormone treatment in a rat model of acute stroke. Brain Res 2013;1513:92-102
   PubMed Web of Science ®Google Scholar
• Hiroi Y, Kim HH, Ying H, et al. Rapid nongenomic actions of thyroid hormone. Proc Natl Acad Sci USA 2006;103(38):14104-9
   Google Scholar
• Mdzinarishvili A, Sutariya V, Talasila PK, et al. Engineering triiodothyronine (T3) nanoparticle for use in ischemic brain stroke. Drug Deliv Transl Res 2013;3(4):309-17
   PubMed Web of Science ®Google Scholar
• Mendes-de-Aguiar CB, Alchini R, Decker H, et al. Thyroid hormone increases astrocytic glutamate uptake and protects astrocytes and neurons against glutamate toxicity. J Neurosci Res 2008;86(14):3117-25
   PubMed Web of Science ®Google Scholar
• Schlenker EH, Hora M, Liu Y, et al. Effects of thyroidectomy, T4, and DITPA replacement on brain blood vessel density in adult rats. Am J Physiol Regul Integr Comp Physiol 2008;294(5):19
   Google Scholar
• Roeder LM, Hopkins IB, Kaiser JR, et al. Thyroid hormone action on glucose transporter activity in astrocytes. Biochem Biophys Res Commun 1988;156(1):275-81
   PubMed Web of Science ®Google Scholar
• Westerholz S, de Lima AD, Voigt T. Regulation of early spontaneous network activity and GABAergic neurons development by thyroid hormone. Neuroscience 2010;168(2):573-89
   PubMed Web of Science ®Google Scholar
• Margaill I, Royer J, Lerouet D, et al. Induction of type 2 iodothyronine deiodinase in astrocytes after transient focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 2005;25(4):468-76
   Google Scholar
• Cui D, Guan Y, Jang H, et al. Expression of monocarboxylate transporter 8 mRNA in the brain tissue of rats with cerebral ischemia. Nan Fang Yi Ke Da Xue Xue Bao 2012;32(6):913-15
   Google Scholar
• Lindestrom E, Boysen G, Waage Christiansen L, et al. Reliability of Scandinavian Neurological Stroke Scale. Cerebrovasc Dis 1991;1:103-11
   Google Scholar
• National Institute of Health NIoNDaS. Stroke Scale. Ed.^(Eds)
   Google Scholar
• Teasdale GM, Drake CG, Hunt W, et al. A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies. J Neurol Neurosurg Psychiatry 1988;51(11):1457
   PubMed Web of Science ®Google Scholar
• Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980;6(1):1-9
   PubMed Web of Science ®Google Scholar
• Bonita R, Beaglehole R. Recovery of motor function after stroke. Stroke 1988;19:1497-500
   PubMed Web of Science ®Google Scholar
• Folstein MF, Folstein SE, McHugh PR. ‘‘Mini-mental state’’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98
   PubMed Web of Science ®Google Scholar
• Olivecrona Z, Dahlqvist P, Koskinen LO. Acute neuro-endocrine profile and prediction of outcome after severe brain injury. Scand J Trauma Resusc Emerg Med 2013;21:33
   PubMed Web of Science ®Google Scholar
• Wittmann G, Harney JW, Singru PS, et al. Inflammation-inducible type 2 deiodinase expression in the leptomeninges, choroid plexus, and at brain blood vessels in male rodents. Endocrinology 2014;155(5):2009-19
   Google Scholar
• Rodriguez-Perez A, Palos-Paz F, Kaptein E, et al. Identification of molecular mechanisms related to nonthyroidal illness syndrome in skeletal muscle and adipose tissue from patients with septic shock. Clin Endocrinol (Oxf) 2008;68(5):821-7
   Google Scholar
• Farwell AP. Nonthyroidal illness syndrome. Curr Opin Endocrinol Diabetes Obes 2013;20(5):478-84
   PubMed Web of Science ®Google Scholar
• Elkind MS. Inflammatory mechanisms of stroke. Stroke 2010;41(10 Suppl):S3-8
   PubMed Web of Science ®Google Scholar
• Zimmermann C, Winnefeld K, Streck S, et al. Antioxidant status in acute stroke patients and patients at stroke risk. Eur Neurol 2004;51(3):157-61
   PubMed Web of Science ®Google Scholar
• Gardner DF, Carithers RLJr, Utiger RD. Thyroid function tests in patients with acute and resolved hepatitis B virus infection. Ann Intern Med 1982;96(4):450-2
   PubMed Web of Science ®Google Scholar
• Vickrey BG. Getting oriented to patient-oriented outcomes. Neurology 1999;53(4):662-3
   Google Scholar
• Reeves MJ, Parker C, Fonarow GC, et al. Development of stroke performance measures: definitions, methods, and current measures. Stroke 2010;41(7):1573-8
   PubMed Web of Science ®Google Scholar
• Sun JH, Tan L, Yu JT. Post-stroke cognitive impairment: epidemiology, mechanisms and management. Ann Transl Med 2014;2(8):80
   PubMedGoogle Scholar
• Dwyer Hollender K. Screening, diagnosis, and treatment of post-stroke depression. J Neurosci Nurs 2014;46(3):135-41
   Google Scholar
• Bunevicius R, Prange AJJr. Thyroid disease and mental disorders: cause and effect or only comorbidity? Curr Opin Psychiatry 2010;23(4):363-8
   PubMed Web of Science ®Google Scholar
• Bunevicius A, Gintauskiene V, Podlipskyte A, et al. Fatigue in patients with coronary artery disease: association with thyroid axis hormones and cortisol. Psychosom Med 2012;74(8):848-53
   PubMed Web of Science ®Google Scholar
• Bunevicius R, Varoneckas G, Prange AJJr, et al. Depression and thyroid axis function in coronary artery disease: impact of cardiac impairment and gender. Clin Cardiol 2006;29(4):170-4
   Google Scholar
• Lymvaios I, Mourouzis I, Cokkinos DV, et al. Thyroid hormone and recovery of cardiac function in patients with acute myocardial infarction: a strong association? Eur J Endocrinol 2011;165(1):107-14
   PubMed Web of Science ®Google Scholar
• Dayan CM, Panicker V. Novel insights into thyroid hormones from the study of common genetic variation. Nat Rev Endocrinol 2009;5(4):211-18
   Google Scholar
• Pingitore A, Galli E, Barison A, et al. Acute effects of triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low-T3 syndrome: a randomized, placebo-controlled study. J Clin Endocrinol Metab 2008;93(4):1351-8
   PubMed Web of Science ®Google Scholar
• Sirlak M, Yazicioglu L, Inan MB, et al. Oral thyroid hormone pretreatment in left ventricular dysfunction. Eur J Cardiothorac Surg 2004;26(4):720-5
   Web of Science ®Google Scholar
• Becker RA, Vaughan GM, Ziegler MG, et al. Hypermetabolic low triiodothyronine syndrome of burn injury. Crit Care Med 1982;10(12):870-5
   Google Scholar
• Guden M, Akpinar B, Saggbas E, et al. Effects of intravenous triiodothyronine during coronary artery bypass surgery. Asian Cardiovasc Thorac Ann 2002;10(3):219-22
   Google Scholar